← Leaderboards
Bobby Thomas
Weill Medical Coll Of Cornell Univ
$7,388,450
Attributed
$8,880,223
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2008–25$2.5M$1.9M$1.3M$625K$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,880,223 · 6
By mechanism
R01$6,161,974 · 4
RF1$2,253,614 · 1
R21$464,635 · 1
Top collaborators
- Michael K Lee2 shared
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Benjamin A Garcia$15,111,941
- Vivek Mittal$10,850,597
- Linda Theresa Vahdat$1,571,187
- Jessica K Tyler$15,598,839
- Raul J. Martinez-McFaline$188,820
Others in their field
Top investigators on “Pathway Interactions”
- David Heimbrook · Leidos Biomedical Research, Inc.$202,777,247
- Ralph Parchment · Leidos Biomedical Research, Inc.$146,974,543
- David R. Weir · University Of Michigan At Ann Arbor$129,316,139
- Daniel Ernest Ford · Johns Hopkins University$108,075,637
- David W Simpson · University Of Southern California$88,046,235
- Charles D. Blanke · Oregon Health And Science University$86,571,896
Research focus
Pathway InteractionsProteinsMouse ModelPathogenesisNerve DegenerationMitochondrial DysfunctionIn VivoMediatingDopaminergic NeuronMutantParkinson DiseaseSignal PathwayEventNew Therapeutic TargetPharmaceutical PreparationsCellsNeuronsAlzheimer&AposKnockout MiceNeuroprotectionGlial Fibrillary Acidic ProteinComplexGenesIntoxication
Grant awards (17)
Neuroprotective mechanisms of Bach1-Derepression in Alzheimerâs Disease$729,933
R01 · FY2025 · AG · contact PI
Molecular Mechanisms of Oxidation Resistance 1 in Parkinson's disease and Lewy Body Dementia$568,064
R01 · FY2025 · NS · contact PI
Molecular Mechanisms of Oxidation Resistance 1 in Parkinson's disease and Lewy Body Dementia$568,064
R01 · FY2024 · NS · contact PI
Molecular Mechanisms of Oxidation Resistance 1 in Parkinson's disease and Lewy Body Dementia$568,064
R01 · FY2023 · NS · contact PI
Neuroprotective mechanisms of Bach1-Derepression in Alzheimerâs Disease$2,253,614
RF1 · FY2022 · AG · contact PI
Role of Bach-1-Mediated Transcriptional Regulation in Neuroprotection$401,686
R01 · FY2021 · NS · contact PI
Role of Bach-1-Mediated Transcriptional Regulation in Neuroprotection$411,772
R01 · FY2020 · NS · contact PI
Role of Bach-1-Mediated Transcriptional Regulation in Neuroprotection$374,059
R01 · FY2019 · NS · contact PI
Role of Bach1-mediated transcriptional regulation in neuroprotection$380,315
R01 · FY2018 · NS · contact PI
Role of Bach1-mediated transcriptional regulation in neuroprotection$380,315
R01 · FY2017 · NS · contact PI
Role of MyD88-5 in the pathogenesis of Parkinson's disease$314,229
R01 · FY2012 · NS · contact PI
Role of MyD88-5 in the pathogenesis of Parkinson's disease$362,294
R01 · FY2011 · NS · contact PI
Role of MyD88-5 in the pathogenesis of Parkinson's disease$365,991
R01 · FY2010 · NS · contact PI
Activators of Nrf2/ARE pathway as therapeutic target for Parkinson's Disease$232,375
R21 · FY2010 · NS · contact PI
Role of MyD88-5 in the pathogenesis of Parkinson's disease$369,688
R01 · FY2009 · NS · contact PI
Activators of Nrf2/ARE pathway as therapeutic target for Parkinson's Disease$232,260
R21 · FY2009 · NS · contact PI
Role of MyD88-5 in the pathogenesis of Parkinson's disease$367,500
R01 · FY2008 · NS · contact PI